Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × FANG vaccine × Clear all

Phase

Status

Completed 17 Terminated 8 Withdrawn 3 Unknown 3 Temporarily not available 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

pembrolizumab 527 Specimen Handling 431 Carboplatin 397 Magnetic Resonance Spectroscopy 387 Cisplatin 367 Cyclophosphamide 351 Radiotherapy 325 Gemcitabine 277 Bevacizumab 272 Paclitaxel 259 Biopsy 253 Drug Therapy 245 Blood Specimen Collection 226 venetoclax 208 Nivolumab 206 fludarabine 202 Capecitabine 202 Oxaliplatin 198 Docetaxel 189 Injections 181 Fluorouracil 176 Radiosurgery 163 Dexamethasone 163 Rituximab 145 Pemetrexed 143 Standard of Care 138 Surgical Procedures, Operative 136 durvalumab 131 atezolizumab 128 tislelizumab 124

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05807035 2025-09-17

Autologous Tumour Vaccine Trial

Vaxine Pty Ltd

Phase 1 Recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡